Carmichasine B is primarily investigated for its potential antitumor and anticancer properties. It has shown inhibitory effects against certain cancer cell lines by interfering with cell proliferation and inducing apoptosis. Its mechanism may involve modulation of key signaling pathways involved in cell survival and growth, making it a candidate of interest in oncology research. Additionally, Carmichasine B exhibits antimicrobial activity against select pathogenic microorganisms, suggesting possible use in developing novel antimicrobial agents. Due to its bioactive profile, it is also used as a reference compound in natural product chemistry and drug discovery studies aimed at structurally related derivatives.